| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $512.3M | +0.0% |
| Cost of Revenue | $184.2M | +1.7% |
| Gross Profit | $328.2M | -0.9% |
| R&D Expense | $13.4M | -48.2% |
| SG&A Expense | $303.9M | -8.6% |
| Operating Income | -$81.7M | +67.4% |
| Pre-tax Income | -$121.1M | +54.1% |
| Income Tax | $85K | +100.2% |
| Net Income | -$156.2M |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $37.0M | +16.2% |
| Accounts Receivable | $122.8M | -10.1% |
| Inventory | $91.3M | +6.9% |
| Current Assets | $268.0M | -1.7% |
| Total Assets | $810.9M | -40.9% |
| Current Liabilities | $175.5M | -42.3% |
| Long-term Debt | $367.0M | -4.7% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $15.3M | +213.3% |
| Capital Expenditures | $7.4M | -26.7% |
| Investing Cash Flow | $15.8M | +113.6% |
| Financing Cash Flow | -$26.7M | -142.9% |
| Free Cash Flow | $8.0M | +133.9% |
| +1.6% |
| EPS (Basic) | -$2.49 | +3.9% |
| EPS (Diluted) | -$2.49 | +3.9% |
| Total Liabilities |
| $589.8M |
| -42.9% |
| Stockholders' Equity | $173.6M | -45.2% |